Librería: Basi6 International, Irving, TX, Estados Unidos de America
EUR 119,43
Cantidad disponible: 5 disponibles
Añadir al carritoCondición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 141,86
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 165,65
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 179,13
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 173,72
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 165,89
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 170,89
Cantidad disponible: 1 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 191,07
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: moluna, Greven, Alemania
EUR 153,91
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dr. Parteek Prasher, an Associate Professor in the Department of Chemistry at the University of Petroleum & Energy Studies, possesses 8 years of research experience in medicinal chemistry and biomaterials. Leading a research team, he focuses on devel.
Idioma: Inglés
Publicado por TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Librería: UK BOOKS STORE, London, LONDO, Reino Unido
EUR 237,60
Cantidad disponible: 13 disponibles
Añadir al carritoCondición: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 249,81
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 328 pages. 10.00x7.00x10.00 inches. In Stock.
Idioma: Inglés
Publicado por Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 137,72
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Librería: CitiRetail, Stevenage, Reino Unido
EUR 141,88
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 194,44
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHRD. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 201,82
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Idioma: Inglés
Publicado por Taylor & Francis Ltd, London, 2025
ISBN 10: 1032812591 ISBN 13: 9781032812595
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 284,09
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapyOffer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapySystematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungsPresents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 265,19
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.